Company Overview and News

 
TRI Pointe Group Strengthens Executive Leadership Team With Three New Hires

2018-05-15 globenewswire
IRVINE, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- TRI Pointe Group, Inc. (NYSE:TPH) announced today the addition of three new senior-level executives to its corporate team to support its family of homebuilder brands: Heather Breidenthal as Chief Human Resources Officer, Jeff Lake as Vice President of Architecture and Design, and Sherri Drew as Vice President of Design Studios. The expansion of the team, which is based in the Irvine, Calif.

 
Lennar (LEN) Down 15.2% Since Earnings Report: Can It Rebound?

2018-05-04 zacks
It has been about a month since the last earnings report for Lennar Corporation (LEN - Free Report) . Shares have lost about 15.2% in that time frame.

 
Lennar (LEN) to Gain From Acquisitions, Weak Margins Hurt

2018-04-16 zacks
Lennar Corporation’s (LEN - Free Report) diversified line of home offerings for first-time, move-up and active adult homebuyers, and positive housing market fundamentals are the driving factors for this leading homebuilder in the United States. Additionally, synergies from its recent acquisitions are also encouraging. Recently, this leading homebuilder reported stellar first quarter of fiscal 2018 results wherein earnings as well as revenues surpassed the Zacks Consensus Estimate by 20.

1
Lennar (LEN) Q1 Earnings & Revenues Top on Strong Demand

2018-04-04 zacks
Lennar Corporation (LEN - Free Report) surpassed earnings as well as revenue expectations in the first quarter of fiscal 2018. The company’s first-quarter adjusted earnings of $1.11 per share surpassed the Zacks Consensus Estimate of 92 cents by 20.7%. The reported figure mainly includes integration costs related to the acquisition of CalAtlantic Group, Inc. and one-time non-cash write down of deferred tax assets due to the reduction in the federal corporate income tax rate.

1
Lennar's (LEN) Q1 Earnings & Revenues Improve Y/Y

2018-04-04 zacks
Lennar Corporation (LEN - Free Report) is one of the leading homebuilders in the United States. With overall housing market recovering at a slow but steady pace, Lennar’s order trends have been improving at a consistent pace. Lennar is performing well on the back of its diverse revenue mix, large land supply, above average order growth and better pricing power. Moreover, Lennar’s ancillary platforms — Rialto, Multi-Family, FivePoint and Financial Services — are evolving and are expected to contribute meaningfully in the near future.

 
UPDATE 2-Homebuilder Lennar quarterly revenue beats on higher demand

2018-04-04 reuters
(Reuters) - U.S. homebuilder Lennar Corp (LEN.N) on Wednesday reported first-quarter revenue above Wall Street targets as it sold more homes at higher prices, indicating robust demand ahead of the crucial spring selling season.

 
How Lennar's (LEN) Margins Are Shaping Up for Q1 Earnings?

2018-04-02 zacks
Lennar Corporation (LEN - Free Report) is set to report first-quarter fiscal 2018 results on Apr 4, before market open. Lennar has been exhibiting solid top-line performances and the trend is expected to continue in the soon-to-be-reported quarter as well, thanks to the strong demand for homes, favorable job market and impressive economic conditions. Let’s take a look at how the company's margin is shaping up for this earnings season.

 
Lennar vs. D.R. Horton: Which Makes a Better Housing Pick?

2018-03-14 zacks
U.S. homebuilding was quite a rage in 2017, giving investors ample scope to rake in handsome gains. The industry is equally attractive this year, courtesy of solid economic growth and job market. Consistent job growth, growing interest from first-time homebuyers as well as high homebuilder confidence are adding to the momentum. Reflecting the positives, total earnings for the construction sector are expected to grow 33.

3
CAA / CalAtlantic Group, Inc. 15-12B

2018-02-26 sec.gov
15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-10959 CalAtlantic Group, Inc. (Exact name of registrant as specified in charter) 700 Northwest 107th Avenue Miami, Florida 33172 (305) 559-4000 (Address, including

9
CAA / CalAtlantic Group, Inc. 8-K (Current Report)

2018-02-13 sec.gov
8-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 12, 2018 Date of Report (Date of earliest event reported)     CALATLANTIC GROUP, INC. (Exact name of registrant as specified in its charter)       Delaware   1-10959   33-0475989 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.

 
CalAtlantic Group (CAA) a Buy at recent price of $53.12, on Solid Quant Score

2018-02-13 investorplace
Currently, CalAtlantic Group Inc (NYSE:CAA) has a Buy using Portfolio Grader's algorithmic stock evaluator. This analytical tool assesses stocks by employing proprietary fundamental and quantitative algorithmic. This represents no change from the previous week and is the same ranking CAA has had from Portfolio Grader for 3 months. The Buy recommendation for CalAtlantic Group Inc is the outcome of a process of analysis that is proprietary which yielded conclusions that were above average in 5 area: an economic sector rated above average in attractiveness, an industry group ranked above average in attractiveness, a ranking in the company's sector that is in the top third, ranking in its industry group that is in the top half, and a quantitative risk/reward calculation that is very attractive; and produced below average results in 1 areas: an analytical score that is below average.

1
CAA / CalAtlantic Group, Inc. / VANGUARD GROUP INC - 3G (Passive Investment)

2018-02-08 sec.gov
calatlanticgroupinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 0 )*       Name of issuer:  CalAtlantic Group Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  128195104     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (

 
CAA / CalAtlantic Group, Inc. / VANGUARD GROUP INC - 3G (Passive Investment)

2018-02-08 sec.gov
calatlanticgroupinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 0 )*       Name of issuer:  CalAtlantic Group Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  128195104     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (

 
CAA / CalAtlantic Group, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-02-08 sec.gov
us1281951046_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) CALATLANTIC GROUP INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 128195104 -------------------------------------------------------- (CUSIP Number) December 31, 2017 ------------------------------------------------

1
CAA / CalAtlantic Group, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-02-08 sec.gov
us1281951046_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) CALATLANTIC GROUP INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 128195104 -------------------------------------------------------- (CUSIP Number) December 31, 2017 ------------------------------------------------

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 128195104